Avidity Partners Management LP Talaris Therapeutics, Inc. Transaction History

Avidity Partners Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.89 - $16.56 $3.14 Million - $7.54 Million	-455,037 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.18 - $17.0 $450 - $629	37 Added 0.01%	455,037 $6.96 Million
Q3 2021 Nov 15, 2021	BUY	$11.61 - $15.99 $216,375 - $298,005	18,637 Added 4.27%	455,000 $6.17 Million
Q2 2021 Aug 16, 2021	BUY	$12.25 - $18.61 $5.35 Million - $8.12 Million	436,363 New	436,363 $6.41 Million

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

Stay updated on Avidity Partners Management LP with notifications on news.